SCHEMBL20108795

SCHEMBL20108795

Clc1ccc(-c2nnc(N3CCN(c4ccccn4)CC3)c3ccccc23)cc1

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.81
KMT2A Q03164 4/20 0.81
MEN1 O00255 3/20 0.81
LMNA P02545 2/20 0.81
MAPT P10636 2/20 0.81
HTT P42858 2/20 0.81
ALDH1A1 P00352 2/20 0.81
MAPK1 P28482 3/20 0.77
POLB P06746 1/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
HSD17B10 Q99714 1/20 0.77
SMO Q99835 3/20 0.59
BCHE P06276 1/20 0.56
ACHE P22303 1/20 0.56
BACE1 P56817 1/20 0.56
KDR P35968 2/20 0.53
KDM4E B2RXH2 1/20 0.50
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13977440 0.89 NPSR1 (1.00) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL20108763 0.81 KMT2A (1.00) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL2023384 0.81 KMT2A (0.74) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL21221773 0.79 KMT2A (0.71) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL20108806 0.76 KMT2A (0.70) NPSR1KMT2AMEN1ALDH1A1MAPK1
SCHEMBL21239113 0.76 HSD17B10 (0.80) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL20109592 0.75 KMT2A (0.65) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL20109369 0.74 KDR (0.78) KMT2AALDH1A1SMN1; SMN2SMOKDR
SCHEMBL20109396 0.74 KMT2A (0.64) NPSR1KMT2AMEN1LMNAMAPT
SCHEMBL26118631 0.74 KAT2B (0.49) NPSR1KMT2AMEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947241-B2 Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) 2021-03-16 US disclosed
US-20190241574-A1 PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME SEOUL NATIONAL UNIVERSITY HOSPITAL (KR) 2019-08-08 US disclosed
WO-2018080216-A1 PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190241574-A1 PHENYL PHTHALAZINE DERIVATIVE, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME PAH, HDAC5, SLC5A1 NPSR1 1730/4885KMT2A 804/4885MEN1 1004/4885
US-10947241-B2 Phenyl phthalazine derivative, method for the preparation thereof, and pharmaceutical composition comprising the same PAH, HDAC5, SLC5A1 NPSR1 1730/4885KMT2A 804/4885MEN1 1004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.